当前位置：药药网 / 数据中心 /奥大利亚药品评审报告(本栏目收费,不能显示细节,电话13136136841)
药品名称：
活性成份：
发布日期：-
奥大利亚药品评审报告745个记录(本栏目收费,不能显示细节,电话13136136841)
奥大利亚药品评审报告
61
PecFent
Fentanyl (as citrate)
2013/3/19
62
Endometrin Pessaries
Progesterone
2013/6/12
63
Zinforo
Ceftaroline fosamil
2013/5/22
64
Oracea
Doxycycline monohydrate
2013/6/6
65
Celsentri
Maraviroc
2013/5/12
66
Aubagio / Teriflunomide Winthrop / Teriflunomide Sanofi
Teriflunomide
2013/5/21
67
Picato 0.015% and 0.05% gel
Ingenol mebutate
2013/6/6
68
Myfortic
Mycophenolate sodium
2013/5/17
69
Flutiform
Fluticasone propionate / Eformoterol fumarate dihydrate
2013/6/13
70
Caprelsa
Vandetanib
2013/8/7
71
Juvicor / Xelezor / Tesozor
Sitagliptin / Simvastatin
2013/6/6
72
Dymista/Dylastine
Fluticasone propionate / azelastine hydrochloride
2014/7/24
73
Sovaldi
Sofosbuvir
2014/8/5
74
Cimzia
Certolizumab
2014/8/15
75
Gazyva
Obinutuzumab
2014/8/26
76
Abasria / Abasria KwikPen
Insulin glargine
2015/8/20
77
Optaflu
Inactivated influenza virus vaccine (containing 15 μg haemagglutinin of virus Types A H1N1+ A H3N2 + B)
2015/8/24
78
Decapeptyl
Triptorelin acetate
2015/8/24
79
MabThera
Rituximab
2015/8/27
80
Hemangiol
Propranolol hydrochloride
2015/8/19